Schmitz M - Search Results

1

SIMOA Diagnostics on Alzheimer's Disease and Frontotemporal Dementia.

Chatziefstathiou A, Canaslan S, Kanata E, Vekrellis K, Constantinides VC, Paraskevas GP, Kapaki E, Schmitz M, Zerr I, Xanthopoulos K, Sklaviadis T, Dafou D. Chatziefstathiou A, et al. Among authors: schmitz m. Biomedicines. 2024 Jun 4;12(6):1253. doi: 10.3390/biomedicines12061253. Biomedicines. 2024. PMID: 38927460 Free PMC article.

2

Amyloid-β 1-42 levels are modified by apolipoprotein E ε4 in Creutzfeldt-Jakob disease in a similar manner as in Alzheimer's disease.

Varges D, Jung K, Gawinecka J, Heinemann U, Schmitz M, von Ahsen N, Krasnianski A, Armstrong VW, Zerr I. Varges D, et al. Among authors: schmitz m. J Alzheimers Dis. 2011;23(4):717-26. doi: 10.3233/JAD-2010-101527. J Alzheimers Dis. 2011. PMID: 21157024

3

Effect of cavtratin, a caveolin-1 scaffolding domain peptide, on oligodendroglial signaling cascades.

Schmitz M, Zerr I, Althaus HH. Schmitz M, et al. Cell Mol Neurobiol. 2011 Oct;31(7):991-7. doi: 10.1007/s10571-011-9694-1. Epub 2011 Apr 27. Cell Mol Neurobiol. 2011. PMID: 21523467 Free PMC article.

4

Desmoplakin as a potential candidate for cerebrospinal fluid marker to rule out 14-3-3 false positive rates in sporadic Creutzfeldt-Jakob disease differential diagnosis.

Gawinecka J, Ciesielczyk B, Sanchez-Juan P, Schmitz M, Heinemann U, Zerr I. Gawinecka J, et al. Among authors: schmitz m. Neurodegener Dis. 2012;9(3):139-44. doi: 10.1159/000334499. Epub 2011 Dec 31. Neurodegener Dis. 2012. PMID: 22213780

5

Impact of the cellular prion protein on amyloid-β and 3PO-tau processing.

Schmitz M, Wulf K, Signore SC, Schulz-Schaeffer WJ, Kermer P, Bähr M, Wouters FS, Zafar S, Zerr I. Schmitz M, et al. J Alzheimers Dis. 2014;38(3):551-65. doi: 10.3233/JAD-130566. J Alzheimers Dis. 2014. PMID: 24028865 Free article.

6

Anchorless 23-230 PrPC interactomics for elucidation of PrPC protective role.

Zafar S, Asif AR, Ramljak S, Tahir W, Schmitz M, Zerr I. Zafar S, et al. Among authors: schmitz m. Mol Neurobiol. 2014 Jun;49(3):1385-99. doi: 10.1007/s12035-013-8616-2. Epub 2014 Jan 5. Mol Neurobiol. 2014. PMID: 24390569

7

Characteristic CSF prion seeding efficiency in humans with prion diseases.

Cramm M, Schmitz M, Karch A, Zafar S, Varges D, Mitrova E, Schroeder B, Raeber A, Kuhn F, Zerr I. Cramm M, et al. Among authors: schmitz m. Mol Neurobiol. 2015 Feb;51(1):396-405. doi: 10.1007/s12035-014-8709-6. Epub 2014 May 9. Mol Neurobiol. 2015. PMID: 24809690 Free PMC article.

8

Immune responses in rapidly progressive dementia: a comparative study of neuroinflammatory markers in Creutzfeldt-Jakob disease, Alzheimer's disease and multiple sclerosis.

Stoeck K, Schmitz M, Ebert E, Schmidt C, Zerr I. Stoeck K, et al. Among authors: schmitz m. J Neuroinflammation. 2014 Oct 15;11:170. doi: 10.1186/s12974-014-0170-y. J Neuroinflammation. 2014. PMID: 25315814 Free PMC article.

9

Behavioral abnormalities in prion protein knockout mice and the potential relevance of PrP(C) for the cytoskeleton.

Schmitz M, Zafar S, Silva CJ, Zerr I. Schmitz M, et al. Prion. 2014;8(6):381-6. doi: 10.4161/19336896.2014.983746. Prion. 2014. PMID: 25517431 Free PMC article.

10

Cerebrospinal fluid tau levels are a marker for molecular subtype in sporadic Creutzfeldt-Jakob disease.

Karch A, Hermann P, Ponto C, Schmitz M, Arora A, Zafar S, Llorens F, Müller-Heine A, Zerr I. Karch A, et al. Among authors: schmitz m. Neurobiol Aging. 2015 May;36(5):1964-8. doi: 10.1016/j.neurobiolaging.2015.01.021. Epub 2015 Feb 7. Neurobiol Aging. 2015. PMID: 25749129

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,468 results

Search Page

Filters